I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| oligodendrocyte precursor cell | 7 studies | 23% ± 6% | |
| natural killer cell | 6 studies | 17% ± 3% | |
| epithelial cell | 5 studies | 39% ± 15% | |
| CD16-negative, CD56-bright natural killer cell, human | 4 studies | 17% ± 2% | |
| fibroblast | 4 studies | 21% ± 6% | |
| ciliated cell | 4 studies | 29% ± 11% | |
| GABAergic neuron | 4 studies | 25% ± 6% | |
| CD16-positive, CD56-dim natural killer cell, human | 3 studies | 20% ± 1% | |
| conventional dendritic cell | 3 studies | 22% ± 7% | |
| endothelial cell | 3 studies | 24% ± 9% | |
| neuron | 3 studies | 26% ± 11% | |
| glutamatergic neuron | 3 studies | 36% ± 5% | |
| goblet cell | 3 studies | 20% ± 6% | |
| basal cell | 3 studies | 28% ± 9% | |
| oligodendrocyte | 3 studies | 19% ± 0% | |
| astrocyte | 3 studies | 19% ± 2% |
